Celyad Announces First Quarter 2017 Business Update
MONT-SAINT-GUIBERT, Belgium, May 19, 2017 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a leader in the discovery and development of cell therapies, today provided an update on key clinical and operational developments for …